Opinion|Videos|February 7, 2025
Therapy Sequencing in CLL
Panelists discuss how therapy sequencing is approached for patients with chronic lymphocytic leukemia (CLL), with a focus on how prior therapy exposure influences the choice of subsequent treatments.
Advertisement
Episodes in this series
- How do you sequence therapies for patients with CLL, and how does prior therapy exposure influence your subsequent choice of treatments?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Prior Authorization Ranked Top Barrier to Health Care Access After Cost
2
FDA Flags Administration Concerns for Aquestive's Noninvasive Epinephrine Film
3
Contributor: The Majority (57.5%) of Commercially Insured Patients Had 1 or More Chronic Conditions in 2024
4
Vutrisiran Improves Survival, Cardiovascular Outcomes Across Age Groups in ATTR-CM
5
